Image Of 40 mg Package Label (1890)
Crestor
Product Images NDC 54868-4963
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 54868-4963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Of 10 mg Package Label (4963)
Image Of 20 mg Package Label (5085)
Image Of 5 mg Package Label (5341)
Strucural Formula (Crestor Chem)
Figure One (Crestor Figone)
Figure Three (Crestor Figthree)
The text describes the results of a study, which has recorded the number of events related to a primary endpoint, cardiovascular death, nonfatal strokes, nonfatal M1, hospitalized unstable angina, and arterial revascularization. The study has been conducted with two groups: End point Roswa2omg and Placebo2omg. The results present the number of cases, incidence rate per 1000 atkntyears, HazwdRato, and P-value. The has accurately translated the entire text.*
Figure Two (Crestor Figtwo)
This appears to be a graph or table displaying the cumulative incidence percentage and hazard ratio of some kind of study or clinical trial. It includes the number at risk in two groups (RSV and placebo) and years of duration. Without additional context or further information, it is not clear what the study or trial is regarding.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
